Nishiwaki, Masami Takei and Jon T. Giles Hitomi Kobayashi, Yasuyuki Kobayashi, Isamu Yokoe, Noboru Kitamura, Atsuma Nishiwaki, Masami Takei and Jon T. Giles. Reduction with Treatment with the Interleukin 6 Inhibitor Tocilizumab Heart Rate-corrected QT Interval Duration in Rheumatoid Arthritis and Its Reduction with Treatment with the Interleukin 6 Inhibitor Tocilizumab Heart. The Journal of Rheumatology. 2018
Yokoe I, Kobayashi H, Kobayashi Y, Giles JT, Yoneyama K, Kitamura N, Takei M. Impact of tocilizumab on N-terminal pro-brain natriuretic peptide levels in patients with active rheumatoid arthritis without cardiac symptoms. Scandinavian Journal of Rheumatology. 2018. 47. 364-370
Y. Kobayashi, H. Kobayashi, J. Giles, I. Yokoe, A. Nishiwaki, M. Takei. Impact of biological treatment on left ventricular function and morphology in rheumatoid arthritis patients without cardiac symptoms, assessed by cardiac magnetic resonance imaging. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2017. 46. 4. 328-329
Yuko Kaneko, Masaru Kato, Yoshiya Tanaka, Masayuki Inoo, Hitomi Kobayashi-Haraoka, Koichi Amano, Masayuki Miyata, Yohko Murakawa, Hidekara Yasuoka, Shintaro Hirata, et al. Tocilizumab discontinuation after attaining remission in patients with rheumatoid arthritis who were treated with tocilizumab alone or in combination with methotrexate: Results from a prospective randomised controlled study (the second year of the SURPRISE study). Annals of the Rheumatic Diseases. 2018. 77. 1268-1275